{"id":2163,"date":"2010-02-01T12:09:00","date_gmt":"2010-02-01T11:09:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2010\/leserbrief-41"},"modified":"2010-02-01T12:09:00","modified_gmt":"2010-02-01T11:09:00","slug":"leserbrief-41","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2010\/leserbrief-41","title":{"rendered":"Leserbrief"},"content":{"rendered":"<p>Nochmals: Was tun bei Statin-Unvertr\u00e4glichkeit? Prof. Dr. H.G. aus Innsbruck schreibt folgenden Kommentar (stark gek\u00fcrzt) zu unserem Statin-Artikel (1): >> Der ARZNEIMITTELBRIEF r\u00e4t, dass Patienten bei Myalgien unter Statin-Therapie entscheiden sollen, ob sie das Medikament weiter einnehmen. Die angebotenen Alternativen (Absetzen, Versuch mit einem anderen Statin) sollten m.E. erg\u00e4nzt werden durch Kontrolle und gegebenenfalls Korrektur [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nochmals: Was tun bei Statin-Unvertr\u00e4glichkeit? Prof. Dr. H.G. aus Innsbruck schreibt folgenden Kommentar (stark gek\u00fcrzt) zu unserem Statin-Artikel (1): >> Der ARZNEIMITTELBRIEF r\u00e4t, dass Patienten bei Myalgien unter Statin-Therapie entscheiden sollen, ob sie das Medikament weiter einnehmen. Die angebotenen Alternativen (Absetzen, Versuch mit einem anderen Statin) sollten m.E. erg\u00e4nzt werden durch Kontrolle und gegebenenfalls Korrektur [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[1046,167,451,164,449,1166,455,453,456,454,1167,801,1043,505,443,159],"class_list":["post-2163","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-atorvastatin","tag-cholecalciferol","tag-cholesterinsynthese-hemmer","tag-colecalciferol","tag-cse-hemmer","tag-fluvastatin","tag-hmg-coa-reduktase-hemmer","tag-hypercholesterinaemie","tag-lipidsenker","tag-lovastatin","tag-pitavastatin","tag-pravastatin","tag-rosuvastatin","tag-simvastatin","tag-statine","tag-vitamin-d"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2163","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=2163"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2163\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=2163"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=2163"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=2163"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}